Gopi Shankar's most recent trade in Larimar Therapeutics Inc was a trade of 139,838 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Larimar Therapeutics Inc | Gopi Shankar | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2025 | 139,838 | 139,838 | - | - | Stock Option (Right to Buy) | |
| Larimar Therapeutics Inc | Gopi Shankar | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2025 | 23,306 | 50,806 | - | 0 | Common Stock | |
| Larimar Therapeutics Inc | Gopi Shankar | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2024 | 135,000 | 135,000 | - | - | Stock Option (Right to Buy) | |
| Larimar Therapeutics Inc | Gopi Shankar | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2024 | 22,500 | 27,500 | - | 0 | Common Stock | |
| Larimar Therapeutics Inc | Shankar Gopi | Chief Development Officer | Purchase of securities on an exchange or from another person at price $ 3.73 per share. | 07 Dec 2023 | 5,000 | 5,000 | - | 3.7 | 18,662 | Common Stock |
| Larimar Therapeutics Inc | Gopi Shankar | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 180,000 | 180,000 | - | - | Stock Option (Right to Buy) |